Rome Therapeutics
Cambridge, United States· Est.
Rome Therapeutics is discovering and developing therapies targeting repeat genomic elements for oncology and autoimmune diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $72M
About
Rome Therapeutics is discovering and developing therapies targeting repeat genomic elements for oncology and autoimmune diseases.
OncologyImmunologyGenetics & Genomics
Funding History
1Total raised:$72M
Series B$72M